Skip to main content
. 2020 Dec 1;21(23):9172. doi: 10.3390/ijms21239172

Figure 7.

Figure 7

Cytokine-targeted therapies and their outcomes in primary Sjögren’s Syndrome. Current therapies include IL-1R, TNF-α, IL-6R, IL-2, JAK, IFN-α targeting. IL, interleukins; TNF-α, tumor necrosis factor–α; IFN-α, interferon α; and JAK, Janus kinase.